DiscoverNeurology MinuteCMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy
CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

Update: 2024-09-19
Share

Description

Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. 

Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496 

Comments 
In Channel
Neurology on the Hill

Neurology on the Hill

2024-10-2202:03

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

American Academy of Neurology